UK markets closed

Genmab A/S (0MGB.L)

LSE - LSE Delayed price. Currency in DKK
Add to watchlist
2,581.26-9.88 (-0.38%)
At close: 06:18PM BST
Full screen
Previous close2,591.14
BidN/A x N/A
AskN/A x N/A
Day's range2,559.00 - 2,574.00
52-week range2,559.00 - 2,574.00
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)0.62
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Grant of Restricted Stock Units and Warrants to Employees in Genmab

    Company Announcement COPENHAGEN, Denmark; September 20, 2022 – Genmab A/S (Nasdaq: GMAB) announced today that the board decided to grant 19,782 restricted stock units and 19,789 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a right and obligation to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on the date of gr

  • Globe Newswire

    Genmab to Present at Morgan Stanley 20th Annual Global Healthcare Conference

    Media ReleaseCOPENHAGEN, Denmark; September 6, 2022 Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan van de Winkel, Ph.D. and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference at 8:00 AM EDT / 2:00 PM CEST on September 13, 2022. A webcast of the event, which will include brief opening remarks followed by a question-and-answer session, will be available on Genmab’s website at http

  • Globe Newswire

    Completion of share buy-back program

    Company Announcement COPENHAGEN, Denmark; September 1, 2022 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on August 31, 2022. On June 17, 2022 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program. The share buy-back program was expected to be completed no later than August 31, 2022 and comprised up to 370,000 shares. The following tra